Research in Pharmaceutical Biotechnology

  • Abbreviation: Res. Pharm. Biotech.
  • Language: English
  • ISSN: 2141-2324
  • DOI: 10.5897/RPB
  • Start Year: 2009
  • Published Articles: 42

Review

Privatisation of the Central Medical Supplies (CMS) public corporation: Why not?

Gamal K. M. Ali
  • Gamal K. M. Ali
  • Former Department of Pharmaceutical Services and Planning Manager, Federal Ministry of Health, Khartoum, Sudan.
  • Google Scholar
Abdeen M. Omer
  • Abdeen M. Omer
  • Occupational Health Administration, Ministry of Health, Khartoum, Sudan.
  • Google Scholar


  • Article Number - 814DAC7482
  • Vol.3(8), pp. 104-110, August 2011
  •  Accepted: 16 June 2011
  •  Published: 30 August 2011

Abstract

 

To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently a responsibility of the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect the public against counterfeit or low quality medicines, although it is practically possible. There is need to continually evaluate regulations put in place to ensure that the public is protected by promoting the marketing of high quality medicines rather than commercial interests, and that the drug companies are held accountable for their conducts.

 

Key words: Sudan, healthcare, medicines, essential drugs, pharmacy management.